Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;11(4):573-574.
doi: 10.21037/tau-2022-01.

Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population

Shuxiong Zeng  1 , Zhensheng Zhang  1 , Chuanliang Xu  1
Affiliations

Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma's prognosis in Chinese population

Shuxiong Zeng et al. Transl Androl Urol. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-2022-01/coif). The authors have no conflicts of interest to declare.

Comment on

  • Transl Androl Urol. 11:571.

Similar articles

See all similar articles

References

    1. Zeng S, Ying Y, Yu X, et al. Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study. Transl Androl Urol 2021;10:4365-75. 10.21037/tau-21-758 - DOI - PMC - PubMed
    1. Chen XP, Xiong GY, Li XS, et al. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China. BJU Int 2013;112:917-24. 10.1111/bju.12238 - DOI - PubMed
    1. Singla N, Fang D, Su X, et al. A Multi-Institutional Comparison of Clinicopathological Characteristics and Oncologic Outcomes of Upper Tract Urothelial Carcinoma in China and the United States. J Urol 2017;197:1208-13. 10.1016/j.juro.2016.11.094 - DOI - PubMed
    1. Kang YC, Chen MH, Lin CY, et al. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies. Ther Adv Drug Saf 2021;12:2042098621997727. 10.1177/2042098621997727 - DOI - PMC - PubMed
    1. Lu H, Liang Y, Guan B, et al. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma. Theranostics 2020;10:4323-33. 10.7150/thno.43251 - DOI - PMC - PubMed